← Niagen Bioscience, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($2.9m) |
($11.4m)
-288.56%
|
($33.3m)
-192.82%
|
($32.1m)
+3.51%
|
($19.9m)
+38.02%
|
($27.1m)
-36.15%
|
($16.5m)
+39.03%
|
($4.9m)
+70.15%
|
$8.6m
+273.15%
|
$17.4m
+103.30%
|
— | |
| Depreciation, Depletion and Amortization | $332k | $510k | $607k | $762k | $871k | $890k | $869k | $870k | $663k | $612k | $1.7m | |
| Depreciation | $332k | $510k | $607k | $762k | $871k | $890k | $869k | $870k | $663k | $612k | $1.2m | |
| Amortization of Debt Issuance Costs | ($15k) | ($75k) | ($19k) | $846k | ($49k) | ($110k) | ($77k) | ($75k) | ($52k) | ($67k) | — | |
| Amortization of Debt Issuance Costs and Discounts | ($15k) | ($75k) | ($19k) | ($113k) | $0 | ($110k) | ($77k) | ($75k) | ($52k) | ($67k) | — | |
| Amortization of Intangible Assets | $88k | $206k | $235k | $246k | $243k | $225k | $186k | $158k | $151k | $173k | — | |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | — | — | — | — | — | — | — | $0 | — | |
| Share-based Payment Arrangement, Noncash Expense | $1.2m | $4.6m | $6.4m | $7.2m | $6.9m | $6.2m | $5.7m | $4.8m | $3.7m | $6.1m | $6.9m | |
| Share-based Payment Arrangement, Expense | $1.2m | $4.6m | $6.4m | $7.2m | — | — | — | — | — | — | $6.9m | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | — | $1.3m | — | — | — | — | — | — | — | $6.9m | |
| Goodwill, Impairment Loss | $0 | — | — | — | — | — | — | — | — | — | $0 | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | $0 | — | — | — | — | — | — | — | — | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | $4k | $0 | — | $3k | $0 | — | — | |
| Nonoperating Income (Expense) | ($683k) | ($153k) | ($144k) | ($847k) | ($71k) | — | — | — | — | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Inventories | ($241k) | $2.2m | ($2.5m) | ($3.3m) | ($148k) | $1.9m | $1.1m | ($152k) | ($5.3m) | $11.6m | ($6.6m) | |
| Increase (Decrease) in Accounts Payable | ($246k) | ($2.4m) | $5.8m | $78k | ($181k) | $978k | ($744k) | $553k | ($1.1m) | $2.3m | ($4.2m) | |
| Net Cash Provided by (Used in) Operating Activities | ($2.9m) |
($9.8m)
-233.86%
|
($20.9m)
-113.26%
|
($20.4m)
+2.24%
|
($10.6m)
+48.14%
|
($24.2m)
-127.95%
|
($15.1m)
+37.52%
|
$7.1m
+147.14%
|
$12.1m
+70.14%
|
$13.5m
+11.52%
|
$5.9m
-55.95%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.5m | $1.2m | $1.3m | $743k | $47k | $0 | $334k | $148k | $163k | $292k | ($275k) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | ($7k) | ($5.5m) | $0 | ($553k) | — | $0 | $7k | ($5k) | ($19k) | $4k | ($4.8m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | ($5k) | ($1k) | ($7k) | — | $0 | ($7k) | $5k | $19k | ($4k) | ($4.8m) | |
| Payments to Acquire Investments | — | — | — | $49k | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($1.7m) | $4.6m | ($1.8m) | ($249k) | ($165k) | ($409k) | ($334k) | ($143k) | ($143k) | ($292k) | $5.0m | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | ($313k) | $0 | ($65k) | — | — | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | — | $0 | $404k | $0 | — | — | — | — | $0 | $251k | — | |
| Proceeds from Issuance of Common Stock | $5.7m | $46.6m | $0 | $6.8m | $4.9m | $26.7m | $7.7m | $0 | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | $754k |
$48.9m
+6389.50%
|
($90k)
-100.18%
|
$16.9m
+18860.00%
|
$8.7m
-48.77%
|
$36.1m
+317.27%
|
$7.7m
-78.79%
|
($90k)
-101.18%
|
$5.4m
+6065.56%
|
$6.9m
+28.81%
|
($4.7m)
-168.12%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | ($2.1m) | $11.5m | ($7.8m) | $6.9m | $17.3m | $20.1m | $66.7m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $18.8m | $16.7m | $28.2m | $20.4m | $27.3m | $44.7m | $64.8m | $66.7m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $717k | $3.0m | $529k | $1.1m | $4.1m | $9.5m | $0 | $0 | $5.4m | $7.2m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $57k | $41k | $33k | $13k | $1k | $1k | $2k | $1k | $1k | — | |
| Additional Financial Items | ||||||||||||
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | $7k | $5.5m | $0 | $7k | — | $0 | $7k | ($5k) | ($19k) | $4k | — | |
| Gain (Loss) on Disposition of Intangible Assets | — | — | — | — | — | — | — | — | — | $117k | — | |
| Gain (Loss) Related to Litigation Settlement | — | ($746k) | ($746k) | — | — | — | — | — | — | $2.0m | — | |
| General and Administrative Expense | $9.4m | $17.6m | $27.1m | $34.3m | $30.4m | $36.4m | $28.3m | $25.0m | $18.4m | $27.1m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | ($16.5m) | ($33.3m) | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | $5.2m | $0 | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $0 | $0 | — | — | — | — | — | — | $305k | $810k | — | |
| Investment Income, Interest | $2k | — | — | — | — | — | — | — | — | $2.1m | — | |
| Operating Expenses | $14.2m | $26.9m | $49.2m | $57.1m | $55.1m | $68.6m | $61.4m | $56.4m | $53.9m | $66.9m | — | |
| Operating Lease, Expense | — | — | — | $663k | $501k | $1.1m | $1.3m | $1.2m | $1.3m | $1.3m | — | |
| Payments of Financing Costs | $110k | — | — | — | — | — | — | — | — | — | — |